Printer-friendly version
Seventy-second World Health Assembly (A72/1)
Agenda Item: 
11.7 Access to medicines and vaccines

Oxfam statement on medicine

We all agree that availability, price and affordability are critical to patients getting the medicine they need. Yet without transparency on these issues, governments and insurers negotiate in the dark.
High prices are pushing countries rich and poor to cut the use of medicines through, for example pushing the burden of payment on OOP or restricting the use of the medicine. A
Colleague from a developed country said that she could not get HepC medicine until her liver had a certain degree of damage. Parents are fighting for a medicine for their kids with cystic fibrosis in the UK- yet barely questioning the obscene high price.
Few years ago, we faced similar debate at the GF before agreeing to set up the price reporting mechanism, which is now the pride of the GF, the countries and also the fund donors.
Transparency on the cost of RD and the price paid in all countries is critical to negotiate affordable price. What is the point of having wonderful innovation if it does not reach the patient who needs it? This was the case for ARVs where millions were left to die for lack of treatment. Here is your opportunity to avoid such fate for people suffering cancer and other diseases.